Management of Cervical Intraepithelial Neoplasia in Pregnant Women

被引:5
作者
Stuebs, Frederik A. [1 ]
Koch, Martin C. [2 ]
Dietl, Anna K. [1 ]
Schulmeyer, Carla E. [1 ]
Behrens, Annika S. [1 ]
Seibold, Anja [1 ]
Adler, Werner [3 ]
Geppert, Carol [4 ]
Hartman, Arndt [4 ]
Knoll, Antje [5 ]
Beckmann, Matthias W. [1 ]
Gass, Paul [1 ]
Mehlhorn, Grit [1 ,6 ,7 ]
机构
[1] Erlangen Univ Hosp, Dept Gynecol & Obstet, Comprehens Canc Ctr Erlangen, European Metropolitan Area Nuremberg CCC ER EMN, Erlangen, Germany
[2] ANregiomed Ansbach Hosp, Dept Gynecol & Obstet, Ansbach, Germany
[3] Friedrich Alexander Univ Erlangen Nuremberg, Dept Med Informat Biometry & Epidemiol, Erlangen, Germany
[4] Erlangen Univ Hosp, Inst Pathol, Comprehens Canc Ctr Erlangen, European Metropolitan Area Nuremberg CCC EREMN, Erlangen, Germany
[5] Erlangen Univ Hosp, Inst Clin & Mol Virol, Comprehens Canc Ctr Erlangen, European Metropolitan Area Nuremberg CCC ER EMN, Erlangen, Germany
[6] German Canc Soc DKG, Erlangen, Germany
[7] Frauenarztpraxis Erlangen, Comm Cerv Pathol & Colposcopy AG CPC, Erlangen, Germany
关键词
High-grade squamous intraepithelial lesion (HSIL); cervical dysplasia; pregnancy; treatment; mode of delivery; GUIDELINES; COLPOSCOPY; CYTOLOGY;
D O I
10.21873/anticanres.16488
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: The aims of the present study were to evaluate the accuracy of colposcopic findings, investigate the way in which untreated cervical intraepithelial neoplasia (CIN) 2/3 develops during pregnancy, and identify factors associated with regression, persistence, or progression rates. Patients and Methods: In a tertiary gynecology and obstetrics department, 655 pregnant women were seen for colposcopy. The most common reason for referral was abnormal cytology findings. The follow-up findings were analyzed retrospectively on the basis of colposcopic findings and cytological and histological tests. Results: The rate of accuracy for major colposcopic findings was 89.2%. Among the colposcopic findings considered "suspicious for invasion" were invasive carcinoma in 42.9% and CIN 3 in 57.1%. The persistence of CIN 3 postpartum was 80% and the rate of progression 4.1%. The rate of regression for CIN 3 was 21.9%. For CIN 2, the rate of persistence was 37.5%, with a regression rate of 31.3%. The rate of regression was higher after vaginal delivery in comparison with caesarean section. Conclusion: The accuracy rate of colposcopy is comparatively high, at 89.2%. This might be because pregnant women are seen by more experienced examiners in our dysplasia unit. The rate of progression is comparable with that in other studies. Vaginal delivery increases the regression rate. The newborns' birth weight or birth week did not affect the rates of regression or persistence.
引用
收藏
页码:3153 / 3158
页数:6
相关论文
共 22 条
  • [1] 2011 Colposcopic Terminology of the International Federation for Cervical Pathology and Colposcopy
    Bornstein, Jacob
    Bentley, James
    Boesze, Peter
    Girardi, Frank
    Haefner, Hope
    Menton, Michael
    Perrotta, Myriam
    Prendiville, Walter
    Russell, Peter
    Sideri, Mario
    Strander, Bjorrn
    Tatti, Silvio
    Torne, Aureli
    Walker, Patrick
    [J]. OBSTETRICS AND GYNECOLOGY, 2012, 120 (01) : 166 - 172
  • [2] Reliability of colposcopy during pregnancy
    Ciavattini, Andrea
    Serri, Matteo
    Di Giuseppe, Jacopo
    Liverani, Carlo A.
    Fallani, Maria G.
    Tsiroglou, Dimitrios
    Papiccio, Maria
    Carpini, Giovanni Delli
    Pieralli, Annalisa
    Clemente, Nicolo
    Sopracordevole, Francesco
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2018, 229 : 76 - 81
  • [3] High-grade cervical neoplasia during pregnancy: diagnosis, management and postpartum findings
    Coppolillo, Enrique F.
    De Ruda Vega, Hilda Malamud
    Brizuela, Julieta
    Cora Eliseht, Martha
    Barata, Avelino
    Perazzi, Beatriz E.
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2013, 92 (03) : 293 - 297
  • [4] Locally advanced cervical cancer complicating pregnancy: A case of competing risks from the Catholic University of the Sacred Heart in Rome
    De Vincenzo, R.
    Tortorella, L.
    Ricci, C.
    Cavaliere, A. F.
    Zannoni, G. F.
    Cefalo, M. G.
    Scambia, G.
    Fagotti, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 150 (03) : 398 - 405
  • [5] Course of cervical intraepithelial neoplasia diagnosed during pregnancy
    Grimm, Donata
    Lang, Isabelle
    Prieske, Katharina
    Jaeger, Anna
    Mueller, Volkmar
    Kuerti, Sascha
    Burandt, Eike
    Lezius, Susanne
    Schmalfeldt, Barbara
    Woelber, Linn
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (06) : 1503 - 1512
  • [6] Prevention of Cervical Cancer Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up
    Hillemanns, Peter
    Friese, Klaus
    Dannecker, Christian
    Klug, Stefanie
    Seifert, Ulrike
    Iftner, Thomas
    Haedicke, Juliane
    Loening, Thomas
    Horn, Lars
    Schmidt, Dietmar
    Ikenberg, Hans
    Steiner, Manfred
    Freitag, Ulrich
    Siebert, Uwe
    Sroczynski, Gaby
    Sauerbrei, Willi
    Beckmann, Matthias W.
    Gebhardt, Marion
    Friedrich, Michael
    Munstedt, Karsten
    Schneider, Achim
    Kaufmann, Andreas
    Petry, K. Ulrich
    Schaefer, Axel P. A.
    Pawlita, Michael
    Weis, Joachim
    Mehnert, Anja
    Fehr, Mathias
    Grimm, Christoph
    Reich, Olaf
    Arbyn, Marc
    Kleijnen, Jos
    Wesselmann, Simone
    Nothacker, Monika
    Follmann, Markus
    Langer, Thomas
    Jentschke, Matthias
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (02) : 160 - 175
  • [7] Diagnoses and outcomes in cervical cancer screening: A population-based study
    Insinga, RP
    Glass, AG
    Rush, BB
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (01) : 105 - 113
  • [8] European guidelines for clinical management of abnormal cervical cytology, Part 2
    Jordan, J.
    Martin-Hirsch, P.
    Arbyn, M.
    Schenck, U.
    Baldauf, J. -J.
    Da Silva, D.
    Anttila, A.
    Nieminen, P.
    Prendiville, W.
    [J]. CYTOPATHOLOGY, 2009, 20 (01) : 5 - 16
  • [9] Karimi-Zarchi Mojgan, 2013, Int J Biomed Sci, V9, P205
  • [10] Massad L, 2021, Journal of Lower Genital Tract Disease, V16, P172, DOI [10.1097/LGT.0b013-31824bc178, DOI 10.1097/LGT.0B013-31824BC178]